Evidence map›Paper›PMID 38769438›Full record

ArticleThe EMBO journal2024

Energy stress promotes P-bodies formation via lysine-63-linked polyubiquitination of HAX1.

Wanqi Zhan, Zhiyang Li, Jie Zhang, Yongfeng Liu, Guanglong Liu, Bingsong Li, Rong Shen, Yi Jiang, Wanjing Shang, Shenjia Gao and 4 more

Abstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. TRIM23 promotes 5-Fluorouracil resistance in colorectal cancer by upregulating GALNT4 expression.Apoptosis : an international journal on programmed cell death · 2025
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wanqi Zhan *Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Zhiyang Li *Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Jie Zhang *Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-7455-0492
Yongfeng Liu *Radiation Medicine Institute, The First Affiliated Hospital, ZhengZhou University, ZhengZhou, Henan, China.ORCID http://orcid.org/0000-0001-8474-0329
Guanglong LiuDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Bingsong LiDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.ORCID http://orcid.org/0009-0007-7645-581X
Rong ShenDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yi JiangDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Wanjing ShangLymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Shenjia GaoDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Han WuDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Ya'nan WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Wankun ChenDepartment of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China. chen.wankun@zs-hospital.sh.cn.ORCID http://orcid.org/0000-0001-7394-9266
Zhizhang WangDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. wangzz89@smu.edu.cn.ORCID http://orcid.org/0000-0002-4699-953X

Funding

Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality) 202102020162MOST | National Natural Science Foundation of China (NSFC) 82071742,32270926,81901578MOST | National Natural Science Foundation of China (NSFC) 82272192,82281240019STCSM | Program of Shanghai Academic Research Leader (Shanghai Academic Research Leader) 22XD1420400
6 · The paper itself

Abstract

Energy stress, characterized by the reduction of intracellular ATP, has been implicated in various diseases, including cancer. Here, we show that energy stress promotes the formation of P-bodies in a ubiquitin-dependent manner. Upon ATP depletion, the E3 ubiquitin ligase TRIM23 catalyzes lysine-63 (K63)-linked polyubiquitination of HCLS1-associated protein X-1 (HAX1). HAX1 ubiquitination triggers its liquid‒liquid phase separation (LLPS) and contributes to P-bodies assembly induced by energy stress. Ubiquitinated HAX1 also interacts with the essential P-body proteins, DDX6 and LSM14A, promoting their condensation. Moreover, we find that this TRIM23/HAX1 pathway is critical for the inhibition of global protein synthesis under energy stress conditions. Furthermore, high HAX1 ubiquitination, and increased cytoplasmic localization of TRIM23 along with elevated HAX1 levels, promotes colorectal cancer (CRC)-cell proliferation and correlates with poor prognosis in CRC patients. Our data not only elucidate a ubiquitination-dependent LLPS mechanism in RNP granules induced by energy stress but also propose a promising target for CRC therapy.

Indexed as

Adaptor Proteins, Signal TransducingLysineUbiquitinationAdenosine TriphosphateCell Line, TumorCell ProliferationColorectal NeoplasmsCytoplasmic GranulesGTP-Binding ProteinsHEK293 CellsHumansStress, PhysiologicalUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingAdenosine TriphosphateGTP-Binding ProteinsHAX1 protein, humanLysineTRIM23 protein, humanUbiquitin-Protein LigasesEnergy StressHAX1P-bodiesTranslation InhibitionTRIM23

Identifiers

PMID38769438
PMCPMC11217408

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.